AI assistant
SCI Interim / Quarterly Report 2017
52383_rns_2017-07-12_3d70c87c-1ff1-4392-bec0-83ee9443663b.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
員工數Employee:242 設立日期:中華民國七十六年九月十八日 Date of establishment: Sep. 18, 1987 資本額Capital:新台幣795佰萬元(NTD 795mn) 營業項目Business: 原料藥API(58.41%) 中間體Intermediate(30.61%) 特用化學品 Custom-made chemicals(10.98%)
公司概況Outline
| Y2016 | 2017.Q2 | |
|---|---|---|
| 歐 洲Europe |
34.40% | 45.06% |
| 美 洲America |
40.33% | 18.03% |
| 亞 洲Asia |
11.77% | 19.66% |
| 內Taiwan 國 |
11.02% | 16.04% |
| 他 others 其 |
2.48% | 1.21% |
| 計Total 合 |
100.00% | 100.00% |
Unit: K NTD
| 2017.Jan~May | 2016Y | |
|---|---|---|
| 營收Sales | 511,728 | 1,903,100 |
| 營業成本COGS | (359,928) | (1,112,574) |
| 毛利Gross Profit | 151,800 | 790,526 |
| 毛利率 GP Ratio | 29.7% | 41.5% |
| 營業費用Operating Expenses | (56,844) | (274,069) |
| 營業利益Operating Income | 94,956 | 516,457 |
| 營業外損益Non-Operating In/Ex | (3,917) | (10,758) |
| 稅前淨利 Net Profit before Tax | 91,039 | 505,699 |
| 所得稅Income Tax | (88,744) | |
| 本期淨利Net Profit after Tax | 416,955 |
產品組合-Products
| Y2014 | % | Y2015 | % | Y2016 | % |
|---|---|---|---|---|---|
| VA Series | 21.89% | HOCLQ | 21.52% | HOCLQ | 34.94% |
| PGA | 17.49% | VA Series | 18.21% | PGA | 12.73% |
| LPF.Na | 8.74% | PGA | 17.14% | VA Series | 13.55% |
| S20/38 | 8.25% | LPF.Na | 7.48% | Pent-2 / PEB.Na | 6.70% |
| Pent-2 / PEB.Na | 6.85% | 5-HMT / 5-wing | 4.61% | S-MMAA / Dulo | 5.32% |
| 5-HMT / 5-wing | 4.65% | Pent-2 / PEB.Na | 4.47% | 5-HMT / 5-wing | 5.21% |
| DBS | 4.60% | S20/38 | 4.01% | LPF.Na | 4.01% |
| S-MMAA / Dulo | 2.64% | S-MMAA / Dulo | 3.81% | ||
| Total | 75.11% | Total | 81.25% | Total | 82.46% |
| Product | % | 2017 1H Sales (NT\$) |
|---|---|---|
| S-MMAA / Dulo | 16.4 | 100,508,859 |
| VA series | 14.43 | 88,449,219 |
| LPF.Na | 11.96 | 73,264,404 |
| Pent-2 / PEB.Na | 9.36 | 57,362,144 |
| 5-HMT / 5-wing | 9.23 | 56,582,452 |
| PGA | 5.43 | 33,264,396 |
| MQRT-115 | 5.06 | 30,999,600 |
Hydroxychloroquine sulfate
風濕性關節炎藥物 For rheumatoid arthritis treatment
Unit : K NT\$
產品介紹Product
VA series-
Unit : K NT\$
Valproic Acid, Divalproex Sodium, Sodium Valproate
Di-Va學名藥於2009推出 Di-Va generic came out in 2009
Pyrogallolaldehyde ( PGA) - Benserazide
Unit : K NT\$
治療帕金森氏症之中間體 Intermediate for Parkinson's Disease
產品介紹Product
Pent-2/Pentobarbital Sodium
Unit : K NT\$
鎮定安眠用中間體及原料藥 Intermediate and API for calmative
S-MMAA/Duloxetine
Unit : K NT\$
抗憂鬱症藥物 Antidepressant
2013年底Duloxetine專利到期 Duloxetine's patent expired in the end of 2013
5-HMT/Wing
Unit : K NT\$
愛滋病藥物中間體 For AIDS treatment Intermediates for Ritonavir and Lopinavir
Loxoprofen sodium Unit : K NT\$
抗發炎藥物 日本市場200-300公噸 Anti-inflammatory Japan market:200-300MT
GMP Status(GMP現況)
| API | CGMP | CEP | DMF | MF | DMF |
|---|---|---|---|---|---|
| Certified (TFDA) |
(EDQM) | (USA) | (Japan) | (Canada) | |
| Valproic Acid (*) (#) | 2003 | 2004 | 2003 | 2008 | 2008 |
| Allopurinol | 2004 | 2003 | 2011 | ||
| Sodium Valproate |
2004 | 2006 | |||
| Divalproex Sodium (**)(#) |
2005 | 2005 | 2010 | ||
| Bisoprolol Fumarate |
2006 | ||||
| Pentobarbital Sodium |
2009 | 2 011 |
|||
| Propafenone Hydrochloride |
2010 | 2012 | 2010 | 2012 | 2012 |
| Methylphenidate HCl |
2 011 |
2014 | |||
| Duloxetine Hydrochloride |
2012 | 2014 | 2010/2011 | 2016 | |
| Thiopental | 2012 | ||||
| Loxoprofen Sodium Hydrate |
2012 | 2011 | |||
| Articaine Hydrochloride |
2013 | 2014 | 2014 | ||
| Hydroxychloroquine Sulfate(#) |
2014 | 2014 | 2014 | ||
| Clindamycin Palmitate HCl |
2011 | ||||
| Cyclophosphamide | 2014 | 2012 | |||
| Brinzolamide | 2015 | 2015 | |||
| Probucol | 2015 | 2004 | 2015 | ||
| Atomoxetine HCl | 2016 |
(*)(**) FDA inspection: Nov. 2005 / April 2012, (*) EDQM inspection: Nov. 2010, (#) FDA inspection: Dec. 2014.
